These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 25290459

  • 1. The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
    Wang C, Du X, Yang R, Liu J, Xu D, Shi J, Chen L, Shao R, Fan G, Gao X, Tian G, Zhu Y, Zhang J.
    J Steroid Biochem Mol Biol; 2015 Jan; 145():28-37. PubMed ID: 25290459
    [Abstract] [Full Text] [Related]

  • 2. The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
    Wang C, Luo F, Zhou Y, Du X, Shi J, Zhao X, Xu Y, Zhu Y, Hong W, Zhang J.
    Exp Cell Res; 2016 Jul 15; 345(2):125-33. PubMed ID: 25849092
    [Abstract] [Full Text] [Related]

  • 3. Psoralea corylifolia L. extract ameliorates benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis.
    Kim HJ, Jin BR, An HJ.
    J Ethnopharmacol; 2021 Jun 12; 273():113844. PubMed ID: 33485982
    [Abstract] [Full Text] [Related]

  • 4. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
    Won SH, Lee HJ, Jeong SJ, Lü J, Kim SH.
    Phytother Res; 2012 May 12; 26(5):669-74. PubMed ID: 21997969
    [Abstract] [Full Text] [Related]

  • 5. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
    Chiu SC, Huang SY, Chen SP, Su CC, Chiu TL, Pang CY.
    Prostate Cancer Prostatic Dis; 2013 Dec 12; 16(4):315-22. PubMed ID: 24042854
    [Abstract] [Full Text] [Related]

  • 6. Anabolic effect of the traditional Chinese medicine compound tanshinone IIA on myotube hypertrophy is mediated by estrogen receptor.
    Zhao P, Soukup ST, Hegevoss J, Ngueu S, Kulling SE, Diel P.
    Planta Med; 2015 May 12; 81(7):578-85. PubMed ID: 26018796
    [Abstract] [Full Text] [Related]

  • 7. Traditional Chinese Medicine Danzhi qing'e decoction inhibits inflammation-associated prostatic hyperplasia via inactivation of ERK1/2 signal pathway.
    Liu Y, Shao R, Suo T, Zhu J, Liu E, Wang Y, Miao L, Gao X.
    J Ethnopharmacol; 2023 Jun 12; 309():116354. PubMed ID: 36906158
    [Abstract] [Full Text] [Related]

  • 8. Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase.
    Miao L, Jiao C, Shao R, Qi Y, Fan G, Li X, Wang Y, Zhu Y, Zhang J, Gao X.
    Toxicol Appl Pharmacol; 2019 Oct 15; 381():114637. PubMed ID: 31238046
    [Abstract] [Full Text] [Related]

  • 9. Pharmaceutical evaluation of naftopidil enantiomers: Rat functional assays in vitro and estrogen/androgen induced rat benign prostatic hyperplasia model in vivo.
    Huang JJ, Cai Y, Yi YZ, Huang MY, Zhu L, He F, Liu XW, Huang BY, Yuan M.
    Eur J Pharmacol; 2016 Nov 15; 791():473-481. PubMed ID: 27615445
    [Abstract] [Full Text] [Related]

  • 10. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS.
    Fan GW, Gao XM, Wang H, Zhu Y, Zhang J, Hu LM, Su YF, Kang LY, Zhang BL.
    J Steroid Biochem Mol Biol; 2009 Feb 15; 113(3-5):275-80. PubMed ID: 19429433
    [Abstract] [Full Text] [Related]

  • 11. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM, Sehgal PD, Drew SA, Huang W, Ricke WA.
    Differentiation; 2013 Feb 15; 85(4-5):140-9. PubMed ID: 23792768
    [Abstract] [Full Text] [Related]

  • 12. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo.
    Zhong X, Lin J, Zhou J, Xu W, Hong Z.
    Mol Med Rep; 2015 Aug 15; 12(2):1699-708. PubMed ID: 25825141
    [Abstract] [Full Text] [Related]

  • 13. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R, Miao L, Yu X, Orgah JO, Barnabas O, Chang Y, Liu E, Fan G, Gao X.
    J Ethnopharmacol; 2019 May 10; 235():65-74. PubMed ID: 30708032
    [Abstract] [Full Text] [Related]

  • 14. Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis.
    Jin BR, An HJ.
    Aging (Albany NY); 2020 Feb 04; 12(3):2142-2155. PubMed ID: 32018227
    [Abstract] [Full Text] [Related]

  • 15. Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia.
    Jin BR, Kim HJ, Park SK, Kim MS, Lee KH, Yoon IJ, An HJ.
    Molecules; 2018 Oct 14; 23(10):. PubMed ID: 30322186
    [Abstract] [Full Text] [Related]

  • 16. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
    Ub Wijerathne C, Park HS, Jeong HY, Song JW, Moon OS, Seo YW, Won YS, Son HY, Lim JH, Yeon SH, Kwun HJ.
    Biol Pharm Bull; 2017 Dec 01; 40(12):2125-2133. PubMed ID: 28943529
    [Abstract] [Full Text] [Related]

  • 17. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R, Aqil F, Jeyabalan J, Gupta RC.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):536-46. PubMed ID: 25304375
    [Abstract] [Full Text] [Related]

  • 18. Anti-Proliferative Effects of Standardized Cornus officinalis on Benign Prostatic Epithelial Cells via the PCNA/E2F1-Dependent Cell Cycle Pathway.
    Jin BR, Cheon SY, Kim HJ, Kim MS, Lee KH, An HJ.
    Int J Mol Sci; 2020 Dec 15; 21(24):. PubMed ID: 33334082
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.
    Rick FG, Schally AV, Block NL, Abi-Chaker A, Krishan A, Szalontay L.
    Prostate; 2013 Jun 15; 73(8):873-83. PubMed ID: 23280565
    [Abstract] [Full Text] [Related]

  • 20. The effect of LHRH antagonist cetrorelix in crossover conditioned media from epithelial (BPH-1) and stromal (WPMY-1) prostate cells.
    Siejka A, Schally AV, Barabutis N.
    Horm Metab Res; 2014 Jan 15; 46(1):21-6. PubMed ID: 23839655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.